Follow RSS for latest reports on this topicInflammatory Bowel Disease (IBD) - Market Research and Reports

Irritable Bowel Syndrome - Pipeline Review, H2 2018 [Report Updated: 13-11-2018]

Irritable Bowel Syndrome - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2018, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Sym...Read More >>>

Published:
2018-11-13

Published by: Global Markets Direct

Prices Starting From:
$2000

Competitor Landscape: Inflammatory Bowel Disease (IBD) [Report Updated: 28-09-2018]

Competitor Landscape: Inflammatory Bowel Disease (IBD)SummarySociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the IBD market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher - - Executive Summary: Contains analysis of key market events th...Read More >>>

Published:
2018-09-28

Published by: Global Data

Prices Starting From:
$6400

Digital Landscape: Inflammatory Bowel Disease [Report Updated: 06-09-2018]

Digital Landscape: Inflammatory Bowel DiseaseSummaryThe Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).Key Highlights- US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly bran...Read More >>>

Published:
2018-09-06

Published by: Global Data

Prices Starting From:
$6000

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018 [Report Updated: 31-07-2018]

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Short Bowel Syndrome Global Clinical Trials Review, H2, 2018 provides an overview of Short Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Short Bowel Syndrome. Report includes an overview of trial numbers and their average enroll...Read More >>>

Published:
2018-07-31

Published by: Global Data

Prices Starting From:
$2500

Short Bowel Syndrome - Pipeline Review, H1 2018 [Report Updated: 12-06-2018]

Short Bowel Syndrome - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H1 2018, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2018-06-12

Published by: Global Markets Direct

Prices Starting From:
$2000

Irritable Bowel Syndrome - Pipeline Review, H1 2018 [Report Updated: 08-05-2018]

Irritable Bowel Syndrome - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H1 2018, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Sym...Read More >>>

Published:
2018-05-08

Published by: Global Markets Direct

Prices Starting From:
$2000

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018 [Report Updated: 30-04-2018]

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018 provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inf...Read More >>>

Published:
2018-04-30

Published by: Global Data

Prices Starting From:
$2500

Global Inflammatory Bowel Disease Partnering 2012 to 2018 [Report Updated: 01-03-2018]

• Insight into key deal terms Read More >>>

Published:
2018-03-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2012-2018 [Report Updated: 01-03-2018]

• Insight into key deal terms inRead More >>>

Published:
2018-03-01

Published by: Current Partnering

Prices Starting From:
$1495

Short Bowel Syndrome - Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

DelveInsight's Short Bowel Syndrome - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Short Bowel Syndrome epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Short Bowel Sy...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$3250

Irritable Bowel Syndrome (IBS) -Epidemiology Forecast to 2027 [Report Updated: 14-02-2018]

DelveInsight's Irritable Bowel Syndrome (IBS) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Irritable Bowel Syndrome (IBS) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$3250

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022 [Report Updated: 29-01-2018]

“The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period.”The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to ...Read More >>>

Published:
2018-01-29

Published by: MarketsandMarkets

Prices Starting From:
$5650

Global Irritable Bowel Syndrome (IBS) Market Research Report 2018 [Report Updated: 12-01-2018]

SummaryIrritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is...Read More >>>

Published:
2018-01-12

Published by: HeyReport

Prices Starting From:
$3500

Global Inflammatory Bowel Disease Drugs Market Research Report Forecast 2017 to 2022 [Report Updated: 18-12-2017]

Delivery of the Report will take 2-3 working days once order is placed.The Global Inflammatory Bowel Disease Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Inflammatory Bowel Disease Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The ...Read More >>>

Published:
2017-12-18

Published by: S&P Consulting

Prices Starting From:
$2800

Irritable Bowel Syndrome - Pipeline Review, H2 2017 [Report Updated: 07-11-2017]

Irritable Bowel Syndrome - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune respo...Read More >>>

Published:
2017-11-07

Published by: Global Markets Direct

Prices Starting From:
$2000

Global Inflammatory Bowel Disease Partnering 2010 to 2017 [Report Updated: 01-11-2017]

• Insight into key deal terms Read More >>>

Published:
2017-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2010-2017 [Report Updated: 01-11-2017]

• Insight into key deal terms inRead More >>>

Published:
2017-11-01

Published by: Current Partnering

Prices Starting From:
$1495

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2026 [Report Updated: 01-11-2017]

EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2026SummaryIrritable bowel syndrome (IBS) is a chronic, relapsing gastrointestinal (GI) disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional GI disorder.For this ana...Read More >>>

Published:
2017-11-01

Published by: Global Data

Prices Starting From:
$3995

Inflammatory Pain Global Clinical Trials Review, H2, 2017 [Report Updated: 31-10-2017]

Inflammatory Pain Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H2, 2017 provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top ...Read More >>>

Published:
2017-10-31

Published by: Global Data

Prices Starting From:
$2500

Irritable Bowel Syndrome (IBS) -Epidemiology Forecast to 2025 [Report Updated: 10-10-2017]

DelveInsight “Irritable Bowel Syndrome (IBS) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Irritable Bowel Syndrome (IBS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Irritable Bowel Syndrome (IBS) prevalent or incident cases segmented by age, sex and subpopula...Read More >>>

Published:
2017-10-10

Published by: Delve Insight

Prices Starting From:
$2750

Short Bowel Syndrome - Epidemiology Insights to 2025 [Report Updated: 31-07-2017]

DelveInsight’s “Short Bowel Syndrome -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Short Bowel Syndrome in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Short Bowel Syndrome. The Report also discusses the prevailing risk factors, disease burden with special emphasis...Read More >>>

Published:
2017-07-31

Published by: Delve Insight

Prices Starting From:
$2950

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017 [Report Updated: 30-06-2017]

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017, provides an overview of the Opioid-Induced Bowel Dysfunction (OBD or OIBD) (Toxicology) pipeline landscape.Opioid-induced bowel dysfunction (OIBD) is refers to a...Read More >>>

Published:
2017-06-30

Published by: Global Markets Direct

Prices Starting From:
$2000

Short Bowel Syndrome - Pipeline Review, H1 2017 [Report Updated: 13-06-2017]

Short Bowel Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H1 2017, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2017-06-13

Published by: Global Markets Direct

Prices Starting From:
$2000

Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease, [Report Updated: 24-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS FOR STAKEHOLDERS1.3. KEY MARKET SEGMENTS1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.4.3. Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. OVERVIEW OF IVIG3.2.1. Patented products3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHR...Read More >>>

Published:
2017-05-24

Published by: Allied Market Research

Prices Starting From:
$2850

Irritable Bowel Syndrome - Pipeline Review, H1 2017 [Report Updated: 23-05-2017]

Irritable Bowel Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H1 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune respo...Read More >>>

Published:
2017-05-23

Published by: Global Markets Direct

Prices Starting From:
$2000

Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027 [Report Updated: 01-02-2017]

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 Major MarketsIrritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group of symptoms but includes abdominal pain and disturbed defecation. IBS is divided into several subtypes including: • Diarrhoea predominant (IBS-D)• Constipation predominant (IBS-C)• Alternatin...Read More >>>

Published:
2017-02-01

Published by: Black Swan Analysis

Prices Starting From:
$6100

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Bowel Dysfunction – Pipeline Review, H2 2016, provides an overview of the Opioid-Induced Bowel Dysfunction (Toxicology) pipeline landscape.Opioid-induced bowel dysfunction (OIBD) is refers to a collection of primarily g...Read More >>>

Published:
2016-12-30

Published by: Global Markets Direct

Prices Starting From:
$2000

Short Bowel Syndrome - Pipeline Review, H2 2016

Short Bowel Syndrome - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome – Pipeline Review, H2 2016, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the s...Read More >>>

Published:
2016-12-14

Published by: Global Markets Direct

Prices Starting From:
$2000

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2016 provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and thei...Read More >>>

Published:
2016-11-30

Published by: Global Data

Prices Starting From:
$2500

Inflammatory Pain Global Clinical Trials Review, H2, 2016

Inflammatory Pain Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H2, 2016 provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top ...Read More >>>

Published:
2016-11-30

Published by: Global Data

Prices Starting From:
$2500

Global Inflammatory Bowel Disease Partnering 2010 to 2016

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2010-2016

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other DiseasesThis Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory & Other Diseases evaluates the competitive landscape of bispecific therapeutic antibodies for treatment of cancer, anti-inflammatory & autoimmune diseaseas as well as cardiometabolic, infectious, neurologic, o...Read More >>>

Published:
2016-06-01

Published by: La Merie

Prices Starting From:
$560

Inflammatory Pain Global Clinical Trials Review, H1, 2016

Inflammatory Pain Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2016 provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top ...Read More >>>

Published:
2016-03-16

Published by: Global Data

Prices Starting From:
$2500

Uveitis treatment Market: By Disease Type(Anterior (Acute), Posterior, Intermediate & Pan uveitis), By Treatment (Anti-inflammatory Medicines, Antibiotic or antiviral medicines & Immunosuppressive medicines) & By Geography-Forecast (2016-2021) [Report Updated: 25-02-2016]

Uveitis can be defined as an internal inflammation of the eye. The condition involves the middle layers of the eye, also called the uveal tract or uvea. The uvea includes the iris (colored part of the eye), choroid (a thin membrane containing many blood vessels), and the ciliary body (the part of the eye that joins these together). Uveitis is caused due to infection with a virus, fungus, bacteria,...Read More >>>

Published:
2016-02-25

Published by: Industry ARC

Prices Starting From:
$5250

Inflammatory Bowel Disease Market: By Product Type (Aminosalicylates, Antibiotics, Corticosteroids, Biologic therapies, & Immunomodulators), By Application (Therapeutic & Diagnostics), By Disease Condition & Geography-Forecast (2016-2021) [Report Updated: 03-02-2016]

Inflammatory bowel disease (IBD) related to the digestive systems of the human being which can be identified by chronic inflammation of all or part of your digestive tract. This disease primarily includes ulcerative colitis and Crohn's disease. This report identifies the Inflammatory Bowel Disease market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the...Read More >>>

Published:
2016-02-03

Published by: Industry ARC

Prices Starting From:
$5250

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015 provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inf...Read More >>>

Published:
2015-12-30

Published by: Global Data

Prices Starting From:
$2500

Short Bowel Syndrome Global Clinical Trials Review, H2, 2015

Short Bowel Syndrome Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Short Bowel Syndrome Global Clinical Trials Review, H2, 2015 provides an overview of Short Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Short Bowel Syndrome. Report includes an overview of trial numbers and their average enroll...Read More >>>

Published:
2015-12-16

Published by: Global Data

Prices Starting From:
$2500

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015

Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015 provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Irritable Bowel Syndrome. Report includes an overview of trial numbers and thei...Read More >>>

Published:
2015-12-16

Published by: Global Data

Prices Starting From:
$2500

Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders

IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologists in UK, France, Germany, Spain and Italy, Medical Affairs Reputations (EU5): Biosimilar mAbs in Inflammatory Disorders offers insights on how Medical Affairs teams from companies developing and marketing biosimilar anti-TNF monoclonal antibodies (mAbs) can best meet physician needs on various suppo...Read More >>>

Published:
2015-02-01

Published by: FirstWord Pharma

Prices Starting From:
$5995